SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "(WFRF:(Larsson Helena)) "

Sökning: (WFRF:(Larsson Helena))

  • Resultat 1-10 av 527
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Ludvigsson, Johnny, et al. (författare)
  • GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus
  • 2012
  • Ingår i: New England Journal of Medicine. - : Massachusetts Medical Society. - 0028-4793 .- 1533-4406. ; 366:5, s. 433-442
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The 65-kD isoform of glutamic acid decarboxylase (GAD65) is a major autoantigen in type 1 diabetes. We hypothesized that alum-formulated GAD65 (GAD-alum) can preserve beta-cell function in patients with recent-onset type 1 diabetes.METHODS: We studied 334 patients, 10 to 20 years of age, with type 1 diabetes, fasting C-peptide levels of more than 0.3 ng per milliliter (0.1 nmol per liter), and detectable serum GAD65 autoantibodies. Within 3 months after diagnosis, patients were randomly assigned to receive one of three study treatments: four doses of GAD-alum, two doses of GAD-alum followed by two doses of placebo, or four doses of placebo. The primary outcome was the change in the stimulated serum C-peptide level (after a mixed-meal tolerance test) between the baseline visit and the 15-month visit. Secondary outcomes included the glycated hemoglobin level, mean daily insulin dose, rate of hypoglycemia, and fasting and maximum stimulated C-peptide levels.RESULTS: The stimulated C-peptide level declined to a similar degree in all study groups, and the primary outcome at 15 months did not differ significantly between the combined active-drug groups and the placebo group (P=0.10). The use of GAD-alum as compared with placebo did not affect the insulin dose, glycated hemoglobin level, or hypoglycemia rate. Adverse events were infrequent and mild in the three groups, with no significant differences.CONCLUSIONS: Treatment with GAD-alum did not significantly reduce the loss of stimulated C peptide or improve clinical outcomes over a 15-month period.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Andersson, Cecilia K, et al. (författare)
  • Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
  • 2013
  • Ingår i: Pediatric Diabetes. - : Hindawi Limited. - 1399-543X .- 1399-5448. ; 14:5, s. 341-349
  • Tidskriftsartikel (refereegranskat)abstract
    • AIMS: Children with type 1 diabetes (T1D) risk and islet autoantibodies are recruited to a secondary prevention study. The aims were to determine metabolic control in relation to human leukocyte antigen (HLA) genetic risk and islet autoantibodies in prepubertal children. METHODS: In 47 healthy children with GADA and at least one additional islet autoantibody, intravenous glucose tolerance test (IvGTT) and oral glucose tolerance test (OGTT) were performed 8-65 d apart. Hemoglobin A1c, plasma glucose as well as serum insulin and C-peptide were determined at fasting and during IvGTT and OGTT. RESULTS: All children aged median 5.1 (4.0-9.2) yr had autoantibodies to two to six of the beta-cell antigens GAD65, insulin, IA-2, and the three amino acid position 325 variants of the ZnT8 transporter. In total, 20/47 children showed impaired glucose metabolism. Decreased (≤30 μU/mL insulin) first-phase insulin response (FPIR) was found in 14/20 children while 11/20 had impaired glucose tolerance in the OGTT. Five children had both impaired glucose tolerance and FPIR ≤30 μU/mL insulin. Number and levels of autoantibodies were not associated with glucose metabolism, except for an increased frequency (p = 0.03) and level (p = 0.01) of ZnT8QA in children with impaired glucose metabolism. Among the children with impaired glucose metabolism, 13/20 had HLA-DQ2/8, compared to 9/27 of the children with normal glucose metabolism (p = 0.03). CONCLUSION: Secondary prevention studies in children with islet autoantibodies are complicated by variability in baseline glucose metabolism. Evaluation of metabolic control with both IvGTT and OGTT is critical and should be taken into account before randomization. All currently available autoantibody tests should be analyzed, including ZnT8QA.
  •  
6.
  • Andersson, Cecilia K, et al. (författare)
  • The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
  • 2011
  • Ingår i: Autoimmunity. - : Informa UK Limited. - 0891-6934 .- 1607-842X. ; 44, s. 394-405
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims: We tested whether autoantibodies to all three ZnT8RWQ variants, GAD65, insulinoma-associated protein 2 (IA-2), insulin and autoantibodies to islet cell cytoplasm (ICA) in combination with human leukocyte antigen (HLA) would improve the diagnostic sensitivity of childhood type 1 diabetes by detecting the children who otherwise would have been autoantibody-negative. Methods: A total of 686 patients diagnosed in 1996-2005 in Skåne were analyzed for all the seven autoantibodies [arginin 325 zinc transporter 8 autoantibody (ZnT8RA), tryptophan 325 zinc transporter 8 autoantibody (ZnT8WA), glutamine 325 Zinc transporter 8 autoantibody (ZnT8QA), autoantibodies to glutamic acid decarboxylase (GADA), Autoantibodies to islet-antigen-2 (IA-2A), insulin autoantibodies (IAA) and ICA] in addition to HLA-DQ genotypes. Results: Zinc transporter 8 autoantibody to either one or all three amino acid variants at position 325 (ZnT8RWQA) was found in 65% (449/686) of the patients. The frequency was independent of age at diagnosis. The ZnT8RWQA reduced the frequency of autoantibody-negative patients from 7.5 to 5.4%-a reduction by 28%. Only 2 of 108 (2%) patients who are below 5 years of age had no autoantibody at diagnosis. Diagnosis without any islet autoantibody increased with increasing age at onset. DQA1-B1(*)X-0604 was associated with both ZnT8RA (p = 0.002) and ZnT8WA (p = 0.01) but not with ZnT8QA (p = 0.07). Kappa agreement analysis showed moderate (>0.40) to fair (>0.20) agreement between pairs of autoantibodies for all combinations of GADA, IA-2A, ZnT8RWQA and ICA but only slight ( < 0.19) agreement for any combination with IAA. Conclusions: This study revealed that (1) the ZnT8RWQA was common, independent of age; (2) multiple autoantibodies were common among the young; (3) DQA1-B1(*)X-0604 increased the risk for ZnT8RA and ZnT8WA; (4) agreement between autoantibody pairs was common for all combinations except IAA. These results suggest that ZnT8RWQA is a necessary complement to the classification and prediction of childhood type 1 diabetes as well as to randomize the subjects in the prevention and intervention of clinical trials.
  •  
7.
  • Barreto Henriksson, Helena, et al. (författare)
  • Determination of mechanical and rheological properties of a cell-loaded peptide gel during ECM production
  • 2019
  • Ingår i: International Journal of Pharmaceutics. - : Elsevier BV. - 0378-5173 .- 1873-3476. ; 563, s. 437-444
  • Tidskriftsartikel (refereegranskat)abstract
    • The development of an injectable biomaterial that supports cell survival and maintains or promotes nucleus pulposus (NP) phenotype could aid delivery of cells to degenerated NPs causing low back pain. Mesenchymal cells were loaded and grown in a synthetic peptide gel, PuraMatrix (R). Cells were observed within the gels over 0-28 days, and accumulation of glycosaminoglycans were detected by histological staining. The mechanical properties of the cell-loaded constructs, and the change of the mechanical properties were studied using stress relaxation of the gels under compression and confinement. The PuraMatrix (R) gel was shown to relax fast on compression indicating that the fluid could easily flow out of the gel, and thus indicating the presence of large pores/voids. The presence of these pores/voids was further supported by high mobility of dextran molecules, determined using fluorescence recovery after photo bleaching. The stress required to deform the cell-loaded constructs to a specific strain increases at day 21, at which point the presence of glycosaminoglycans within the cell-loaded constructs was also observed. The results provide evidence of changes in mechanical properties of the PuraMatrix (R) matrix upon excretion of the extracellular matrix by the cells.
  •  
8.
  •  
9.
  • Bergenfelz, Caroline, et al. (författare)
  • Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
  • 2015
  • Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 10:5
  • Tidskriftsartikel (refereegranskat)abstract
    • Myeloid-derived suppressor cells (MDSCs) are highly immunosuppressive myeloid cells, which increase in cancer patients. The molecular mechanism behind their generation and function is unclear. Whereas granulocytic-MDSCs correlate with poor overall survival in breast cancer, the presence and relevance of monocytic-MDSCs (Mo-MDSCs) is unknown. Here we report for the first time an enrichment of functional blood Mo-MDSCs in breast cancer patients before they acquire a typical Mo-MDSC surface phenotype. A clear population of Mo-MDSCs with the typical cell surface phenotype (CD14+HLA-DRlow/-CD86low/-CD80low/-CD163low/-) increased significantly first during disease progression and correlated to metastasis to lymph nodes and visceral organs. Furthermore, monocytes, comprising the Mo-MDSC population, from patients with metastatic breast cancer resemble the reprogrammed immunosuppressive monocytes in patients with severe infections, both by their surface and functional phenotype but also at their molecular gene expression profile. Our data suggest that monitoring the Mo-MDSC levels in breast cancer patients may represent a novel and simple biomarker for assessing disease progression.
  •  
10.
  • Granström, Beate, 1995, et al. (författare)
  • Getting academic library staff up-to-speed on artificial intelligence
  • 2024
  • Ingår i: LIBER 2024: Slide and Poster Presentations.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
    • With the public release of generative artificial intelligence (AI) tools, most notably ChatGPT in 2022, interest in the technologies has swept across various organizations like wildfire. Higher education institutions and their libraries are no exception. Many academic library staff have found ways to develop their competence around AI and investigate what AI development will mean for academic libraries. Yet, if developing a better understanding for (generative) AI at academic libraries broadly is a goal for the organization, then the question arises of how a large proportion of a library’s staff can be reached, rather than a few engaged individuals, and what aspects of AI will then be relevant to address. These are questions that we have faced in a collaboration between three libraries at universities in western Sweden. In the presentation we will share experiences from this collaborative effort to further professional development among staff members concerning AI in libraries. The program runs during the academic year 2023/2024 and contains several online lectures and two active learning classroom (ALC) sessions. The lectures were streamed live to all staff and were also recorded and made available for the three institutions. The ALC sessions, which allow for active engagement with the technologies as well as other participants on campus, required registration and were attended by a subset of the staff. Although not all staff attended all or even parts of the program, it aimed to reach library staff beyond those who are particularly motivated to learn about AI. Apart from facilitating participation by making it less reliant on participation and time, the lectures and ALC sessions connected closely to issues of relevance in academic libraries, rather than at the university at large, and in different areas of responsibility to boot. They also linked to the local situation at the three universities, thus making them more immediately useful for the everyday work tasks. The fact that the sessions were planned and, for the most part, implemented internally has facilitated maintaining a local focus. Aspects of AI have been addressed from the perspective of their relevance to various library stakeholders (students, researchers, library staff), ongoing development projects have been presented, and issues around bias, privacy, security, and AI literacy have been discussed. In the presentation, we will discuss the challenges of designing content for professional development around AI at a time when so much is happening and happening fast, at the same time as much actual implementation in the library field is in its infancy. We will also share our approach to these challenges, with a particular focus on how to make the content relevant to academic library staff with varying professional backgrounds and working within different specialized areas of responsibility. The presentation aims to raise awareness of, but also problems involved with, how professional development can be conducted within an area such as AI which is at the same time ubiquitous and can be viewed as a very specialized area of expertise.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 527
Typ av publikation
tidskriftsartikel (394)
konferensbidrag (39)
rapport (30)
annan publikation (20)
bokkapitel (12)
doktorsavhandling (9)
visa fler...
forskningsöversikt (9)
samlingsverk (redaktörskap) (5)
bok (4)
konstnärligt arbete (2)
licentiatavhandling (1)
patent (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (411)
övrigt vetenskapligt/konstnärligt (91)
populärvet., debatt m.m. (25)
Författare/redaktör
Larsson, Helena (120)
Lernmark, Åke (85)
Elding Larsson, Hele ... (55)
Lundgren, Markus (43)
Larsson, Helena Eldi ... (38)
Carlsson, Annelie (37)
visa fler...
Ivarsson, Sten (29)
Törn, Carina (26)
Ludvigsson, Johnny (24)
Larsson, Jenny Helen ... (22)
Toppari, Jorma (21)
Ziegler, Anette G. (21)
Akolkar, Beena (21)
Ramelius, Anita (20)
Marcus, Claude (20)
Jahncke, Helena, 198 ... (19)
Haller, Michael J. (18)
Hallman, David, 1979 ... (18)
Veijola, Riitta (17)
Bjärntoft, Sofie (17)
Larsson, Anders (16)
Mathiassen, Svend Er ... (16)
Larsson, Christer (16)
Larsson, Johan, 1979 ... (16)
Samuelsson, Ulf (16)
Vehik, Kendra (16)
Bonifacio, Ezio (16)
Krischer, Jeffrey P. (15)
Hagopian, William A. (14)
She, Jin Xiong (14)
Zetterberg, Camilla, ... (14)
Agardh, Daniel (13)
Kjellberg, Anders (13)
Cilio, Corrado (13)
Jernberg-Wiklund, He ... (13)
Rewers, Marian (13)
Jonsdottir, Berglind (13)
Forsander, Gun, 1951 (13)
Rewers, Marian J. (13)
Bergsten, Eva L., 19 ... (13)
Edvinsson, Johanna (13)
Tegern, Matthias (13)
Salami, Falastin (13)
Larsson, Elna-Marie (12)
Larsson, Karin (12)
Maziarz, Marlena (12)
Lynch, Kristian (11)
Geraghty, Daniel E. (11)
Vaziri Sani, Fariba (11)
Steck, Andrea K. (11)
visa färre...
Lärosäte
Lunds universitet (215)
Uppsala universitet (111)
Karolinska Institutet (97)
Göteborgs universitet (81)
Linköpings universitet (58)
Stockholms universitet (41)
visa fler...
Umeå universitet (35)
Högskolan Kristianstad (25)
Högskolan i Gävle (22)
Sveriges Lantbruksuniversitet (18)
Örebro universitet (14)
Kungliga Tekniska Högskolan (13)
Högskolan Dalarna (13)
Luleå tekniska universitet (11)
Chalmers tekniska högskola (11)
RISE (10)
Jönköping University (7)
Malmö universitet (7)
Högskolan Väst (4)
IVL Svenska Miljöinstitutet (4)
Naturvårdsverket (3)
Mittuniversitetet (3)
Karlstads universitet (3)
Mälardalens universitet (2)
VTI - Statens väg- och transportforskningsinstitut (2)
Havs- och vattenmyndigheten (2)
Högskolan i Halmstad (1)
Södertörns högskola (1)
Gymnastik- och idrottshögskolan (1)
Linnéuniversitetet (1)
Försvarshögskolan (1)
Blekinge Tekniska Högskola (1)
Sophiahemmet Högskola (1)
visa färre...
Språk
Engelska (446)
Svenska (71)
Odefinierat språk (6)
Danska (3)
Franska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (337)
Naturvetenskap (45)
Samhällsvetenskap (40)
Teknik (33)
Humaniora (27)
Lantbruksvetenskap (24)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy